Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 Chambers Michael Andrew Director Grant or award +16,875 27,535
2025-12-18 Chambers Michael Andrew Director Returned to the company · Convertible Senior Notes −0
2025-12-18 Chambers Michael Andrew Director Grant or award · Convertible Senior Notes +0
2025-03-10 Chambers Michael Andrew Director Grant or award +2,383 10,660
2025-03-10 Chambers Michael Andrew Director Grant or award · Stock Options (right to buy) +4,792 4,792
2024-08-16 Chambers Michael Andrew Director Purchase +13,106 $133.07 $1.7M 260,102
2024-08-16 Chambers Michael Andrew Director Purchase +18,284 $134.06 $2.5M 278,386
2024-08-16 Chambers Michael Andrew Director Purchase +5,648 $134.66 $761K 284,034
2024-03-01 Chambers Michael Andrew Director Grant or award +1,846 8,277
2024-03-01 Chambers Michael Andrew Director Grant or award · Stock Option (right to buy) +3,679 3,679
2023-08-14 Chambers Michael Andrew Director Purchase +5,947 $109.19 $649K 242,964
2023-08-14 Chambers Michael Andrew Director Purchase +4,032 $109.89 $443K 246,996
2023-08-11 Chambers Michael Andrew Director Purchase +23,686 $108.05 $2.6M 237,017
2023-08-10 Chambers Michael Andrew Director Purchase +2,206 $104.67 $231K 180,670
2023-08-10 Chambers Michael Andrew Director Purchase +1,091 $105.90 $116K 181,761
2023-08-10 Chambers Michael Andrew Director Purchase +31,570 $106.26 $3.4M 213,331
2023-03-06 Chambers Michael Andrew Director Grant or award +1,523 6,431
2023-03-06 Chambers Michael Andrew Director Grant or award · Stock Option (right to buy) +3,257 3,257
2022-09-14 Chambers Michael Andrew Director Purchase +20,744 $103.87 $2.2M 71,822
2022-09-14 Chambers Michael Andrew Director Purchase +30,106 $104.67 $3.2M 101,928

Page 1 of 2 · 26 trades